Do elevated TgAb and TPOAb indicate thyroid immune reactivity even when TSH and free T4 are normal?

Autoimmune thyroiditis often progresses through a prolonged preclinical phase where localized immune activity occurs before systemic thyroid hormone levels are altered.

Clinical evidence and progression risk

• Elevated thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb) are established serum biomarkers of chronic lymphocytic (Hashimoto's) thyroiditis, even in biochemically euthyroid individuals with normal TSH and free T4 (FT4) levels.
• Longitudinal cohort studies demonstrate that euthyroid individuals who test positive for these antibodies have a 2% to 4% annual risk of progressing to subclinical or overt hypothyroidism.
• This risk of progression increases in correlation with higher baseline TSH levels and elevated antibody titers.

Mechanistic explanations

• The presence of TgAb and TPOAb reflects active autoimmune targeting and localized, immune-mediated cytotoxicity directed at the thyroid parenchyma.
• Histological and cytological assessments of euthyroid, antibody-positive individuals reveal structural damage, including dense lymphocytic infiltration, germinal center formation, and progressive follicular destruction.
• This tissue-level pathology demonstrates that chronic lymphocytic thyroiditis can actively damage thyroid architecture while the remaining functional tissue successfully preserves overall glandular hormone output.

Bottom line

• Elevated TgAb and TPOAb provide clear, evidence-based confirmation of active thyroid immune reactivity and chronic lymphocytic infiltration, demonstrating that localized tissue damage occurs long before the failure of thyroid hormone production or changes in TSH.